DocuSign, Inc. DOCU is expected to report its second quarter fiscal 2024 results, after the closing bell on Sept. 7, 2023.
Analysts expect the company to post quarterly earnings at 66 cents per share, up from year-ago earnings of 44 cents per share. The company’s revenue might come in at $677.56 million, compared to $622.18 million in the year-ago period.
DocuSign shares gained 1% to close at $52.78 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- UBS analyst Karl Keirstead maintained a Sell rating and cut the price target from $48 to $44 on Aug. 28, 2023. This analyst has an accuracy rate of 74%.
- Citigroup analyst Tyler Radke reiterated a Buy rating and boosted the price target from $73 to $78 on June 9, 2023. This analyst has an accuracy rate of 69%.
- JP Morgan analyst Mark Murphy maintained an Underweight rating and raised the price target from $48 to $50 on June 9, 2023. This analyst has an accuracy rate of 77%.
- Wedbush analyst Daniel Ives maintained a Neutral rating and increased the price target from $60 to $67 on June 9, 2023. This analyst has an accuracy rate of 73%.
- Jefferies analyst Brent Thill maintained a Buy rating and boosted the price target from $70 to $80 on March 7, 2023. This analyst has an accuracy rate of 74%.
Read This Next: Top 5 Health Care Stocks That May Fall Off A Cliff
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.